TABLE 1.
Cohort demographic data and HIV-associated treatment and immune parameters
| Parameter | Value by group |
||||
|---|---|---|---|---|---|
| ATB/HIV+ (n = 15) | ATB/HIV− (n = 28) | LTBI/HIV+ (n = 24) | LTBI/HIV− (n = 25) | Control (n = 8) | |
| Demographics | |||||
| Mean age (years ± SD) | 35.5 ± 6.96 | 40.6 ± 9.70 | 33.1 ± 7.57 | 28.6 ± 8.26 | 38.4 ± 15.1 |
| Female (n [%]) | 8/15 (53) | 11/28 (39) | 19/24 (79) | 9/25 (36) | 2/8 (25) |
| HIV parameters | |||||
| ART treatment | 6/15 (40) | 0/24 (0) | |||
| CD4+ T cell count mean (cells/mm3 ± SD) | 189.3 ± 164.9 | 485.3 ± 291.4 | |||
| Viral load mean (copies/ml ± SD) | 185,353 ± 322,623 | 37,977 ± 60,557 | |||